Ärzte in einem Operationssaal (Symbolbild).
Mittwoch, 07.09.2016 22:05 von | Aufrufe: 25

Streamline Health® Reports Second Quarter 2016 Revenues of $7.4 Million; Adjusted EBITDA of $1.6 Million; Net Loss of $(0.7) Million

Ärzte in einem Operationssaal (Symbolbild). © FangXiaNuo / E+ / Getty Images http://www.gettyimages.de/

PR Newswire

ATLANTA, Sept. 7, 2016 /PRNewswire/ -- Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the Looking Glass® platform of integrated solutions, technology-enabled services and analytics supporting revenue cycle optimization for healthcare enterprises in the new value-based world today announced financial results for the second quarter and first half of fiscal 2016, which ended July 31, 2016.

Streamline Health Solutions, Inc. is a healthcare industry leader in capturing, aggregating, and translating enterprise data into knowledge - actionable insights that reduce exposure to risk, enhance operational performance, and improve patient care. Through our Looking Glass(TM) Platform we provide clients with meaningful, intelligent SaaS-based solutions from patient engagement to reimbursement. We share a common calling and commitment to advance the quality of life and the quality of healthcare - for...

Revenues for the three-month period ended July 31, 2016 were $7.4 million, up approximately 10% over $6.7 million in Q1 2016, but down approximately 14% as compared to $8.6 million in the same quarter a year ago, which included $1.6 million of perpetual license revenue as compared to $1.0 million of perpetual license revenue in the current quarter. Recurring revenue comprised 76.7% of total revenue in the quarter.  Revenues for the first six months of fiscal year 2016 were $14.0 million, down approximately 5.1% versus the first half of fiscal 2015.

Adjusted EBITDA for the second quarter 2016 was $1.6 million, up appreciably from $0.6 million in Q1, but down approximately 21% from $1.9 million in second quarter of 2015.  Net loss for the second quarter was $(0.7) million, down from $(0.6) million a year prior. Adjusted EBITDA for the first six months of 2016 was $2.2 million, a significant increase over $0.6 million in the first half of fiscal 2015. Net loss for the first half of 2016 was $(2.2) million, an improvement from $(2.4) million for first half of 2015.

"Our second quarter financial performance was a solid improvement over the first quarter of this year as expected, with revenue up nicely and Adjusted EBITDA up significantly" stated David Sides, President and Chief Executive Officer, Streamline Health.  "Bookings improved materially over first quarter to $1.7 million.  As previously communicated, we believe our bookings will accelerate in the second half of this fiscal year as our investment in sales and marketing takes hold."

Highlights for the second quarter ended July 31, 2016 included:

  • Revenue for the second quarter 2016 was $7.4 million;
  • Adjusted EBITDA for the second quarter 2016 was $1.6 million;
  • Net loss for the second quarter 2016 was $(0.7) million;
  • New sales bookings for the quarter were $1.7 million; and
  • Backlog at the end of the quarter was $53.6 million.

Conference Call Information

The Company will conduct a conference call to review the results on Wednesday, September 7, 2016 at 5:00 PM ET. Interested parties can access the call by joining the live webcast: click here to register. You can also join by phone by dialing 877-857-6161 and then entering passcode 7923166.


ARIVA.DE Börsen-Geflüster

Kurse

A replay of the conference call will be available from Wednesday, September 7, 2016 at 8:00 PM ET to Monday, September 12, 2016 at 8:00 PM ET by dialing 888-203-1112 and entering passcode 7923166.

*Non-GAAP Financial Measures
Streamline Health reports its financial results in accordance with U.S. generally accepted accounting principles ("GAAP"). Streamline Health's management also evaluates and makes operating decisions using various other measures. One such measure is adjusted EBITDA, which is a non-GAAP financial measure. Streamline Health's management believes that this measure provides useful supplemental information regarding the performance of Streamline Health's business operations.

Streamline Health defines "adjusted EBITDA" as net earnings (loss) before net interest expense, income tax expense (benefit), depreciation and amortization, stock-based compensation expense, transaction expenses and other expenses that do not relate to Streamline Health's core operations. A table illustrating this measure is included in this press release.

About Streamline Health
Streamline Health Solutions, Inc. (NASDAQ: STRM) is a healthcare industry leader in capturing, aggregating, and translating enterprise data into knowledge­ – actionable insights that support revenue cycle optimization for healthcare enterprises.   Our Looking Glass® platform delivers integrated solutions and analytics that enable providers to drive reimbursement in a value-based world. We share a common calling and commitment to advance the quality of life and the quality of healthcare – for society, our clients, the communities they serve, and the individual patient. For more information, please visit our website at www.streamlinehealth.net.

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995
Statements made by Streamline Health Solutions, Inc. that are not historical facts are forward-looking statements that are subject to certain risks, uncertainties and important factors that could cause actual results to differ materially from those reflected in the forward-looking statements included herein. Forward-looking statements contained in this press release include, without limitation, statements regarding the Company's estimates of future revenue, backlog, results of investments in sales and marketing and related expectations and assumptions.  These risks and uncertainties include, but are not limited to, the timing of contract negotiations and execution of contracts and the related timing of the revenue recognition related thereto, the potential cancellation of existing contracts or clients not completing projects included in the backlog, the impact of competitive solutions and pricing, solution demand and market acceptance, new solution development and enhancement of current solutions, key strategic alliances with vendors and channel partners that resell the Company's solutions, the ability of the Company to control costs, availability of solutions from third party vendors, the healthcare regulatory environment, potential changes in legislation, regulation and government funding affecting the healthcare industry, healthcare information systems budgets, availability of healthcare information systems trained personnel for implementation of new systems, as well as maintenance of legacy systems, fluctuations in operating results, effects of critical accounting policies and judgments, changes in accounting policies or procedures as may be required by the Financial Accounting Standards Board or other similar entities, changes in economic, business and market conditions impacting the healthcare industry generally and the markets in which the Company operates and nationally, and the Company's ability to maintain compliance with the terms of its credit facilities, and other risks detailed from time to time in the Streamline Health Solutions, Inc. filings with the U. S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date hereof. The Company undertakes no obligation to publicly release the results of any revision to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.

Company Contact:
Randy Salisbury
SVP, Chief Marketing Officer
(404) 229-4242
randy.salisbury@streamlinehealth.net

 

STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)




Three Months Ended


Six Months Ended



July 31,


July 31,



2016


2015


2016


2015

Revenues:









  Systems sales

$

1,364,771

$

1,941,601

$

1,876,038

$

2,240,217

  Professional services


548,080


659,372


1,238,695


1,010,331

  Maintenance and support


3,732,488


3,627,118


7,488,041


7,281,183

  Software as a service


1,728,724


2,391,008


3,438,510


4,256,810

        Total revenues


7,374,063


8,619,099


14,041,284


14,788,541










Operating expenses:









  Cost of systems sales


671,631


694,794


1,417,115


1,421,585

  Cost of professional services


529,024


647,569


1,167,788


1,419,065

  Cost of maintenance and support


835,353


714,273


1,693,171


1,531,178

  Cost of software as a service


455,370


702,769


939,613


1,441,600

  Selling, general and administrative


3,341,949


3,779,114


6,940,790


8,285,288

  Research and development


2,108,567


2,233,356


3,830,754


4,457,549

        Total operating expenses


7,941,894


8,771,875


15,989,231


18,556,265

Operating loss


(567,831)


(152,776)


(1,947,947)


(3,767,724)

Other expense (income):









  Interest expense

Werbung

Mehr Nachrichten zur Streamline Health Solutions Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News